NCT00998946 2021-11-05
Study of Pralatrexate to Treat Participants With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
Spectrum Pharmaceuticals, Inc
Phase 2 Completed
Spectrum Pharmaceuticals, Inc
Spectrum Pharmaceuticals, Inc
Acrotech Biopharma Inc.
Acrotech Biopharma Inc.
Acrotech Biopharma Inc.
Eli Lilly and Company
Stanford University
Memorial Sloan Kettering Cancer Center
Eli Lilly and Company
Yonsei University
National Cancer Institute (NCI)